The PI3K signaling pathway is also frequently activated in melanoma, often as a consequence of mutations or loss of phosphatase and tensin homolog (PTEN); an inhibitor of protein kinase B (Akt), and further dysregulation of Akt expression [11]. Here, AKT1 is linked to melanoma.